ChengDu ShengNuo Biotec Co.,Ltd. (SHA:688117)
34.75
-1.29 (-3.58%)
Mar 20, 2026, 3:00 PM CST
ChengDu ShengNuo Biotec Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | - | 218.71 | 219.13 | 372.12 | 211.56 |
Trading Asset Securities | - | 20.16 | 50 | - | 200 |
Cash & Short-Term Investments | 294.75 | 238.86 | 269.13 | 372.12 | 411.56 |
Cash Growth | 23.40% | -11.25% | -27.68% | -9.58% | 217.74% |
Accounts Receivable | - | 125.2 | 115.89 | 119.16 | 111.73 |
Other Receivables | - | 7.97 | 10.27 | 23.63 | 9.49 |
Receivables | - | 133.17 | 126.16 | 142.79 | 121.22 |
Inventory | - | 304.75 | 194.33 | 135.43 | 101.36 |
Prepaid Expenses | - | - | 0.22 | - | - |
Other Current Assets | - | 41.42 | 19.47 | 15.54 | 17.85 |
Total Current Assets | - | 718.21 | 609.3 | 665.89 | 652.01 |
Property, Plant & Equipment | - | 727.43 | 483.86 | 285.1 | 238.06 |
Long-Term Investments | - | 111.04 | 94.43 | 55.69 | 9.9 |
Other Intangible Assets | - | 40.2 | 35.48 | 36.3 | 36.48 |
Long-Term Deferred Tax Assets | - | 9.48 | 4.04 | 3.84 | 3.46 |
Long-Term Deferred Charges | - | 14.1 | 19.98 | 15.43 | 10.93 |
Other Long-Term Assets | - | 27.44 | 68.64 | 45.75 | 5.78 |
Total Assets | - | 1,648 | 1,316 | 1,108 | 956.62 |
Accounts Payable | - | 108.54 | 51.05 | 28.55 | 7.83 |
Accrued Expenses | - | 47.46 | 48.12 | 57.01 | 49.65 |
Short-Term Debt | - | 200.16 | 37.03 | 50.41 | 30.05 |
Current Portion of Long-Term Debt | - | 99.63 | 34.05 | 2 | - |
Current Portion of Leases | - | 0.6 | 0.82 | 0.75 | 0.68 |
Current Income Taxes Payable | - | 2.61 | 8.74 | 5.07 | 4.19 |
Current Unearned Revenue | - | 26.89 | 9.53 | 17.99 | 14.59 |
Other Current Liabilities | - | 57.58 | 51.93 | 63.21 | 55.48 |
Total Current Liabilities | - | 543.46 | 241.28 | 225 | 162.46 |
Long-Term Debt | - | 182.03 | 189.19 | 48.05 | - |
Long-Term Leases | - | - | 0.6 | 1.42 | 2.17 |
Long-Term Unearned Revenue | - | 4.09 | 4.56 | 5.72 | 6.85 |
Long-Term Deferred Tax Liabilities | - | - | - | 1.07 | - |
Total Liabilities | - | 729.58 | 435.63 | 281.27 | 171.48 |
Common Stock | - | 112.42 | 112 | 80 | 80 |
Additional Paid-In Capital | - | 389.59 | 379.22 | 408.36 | 407.25 |
Retained Earnings | - | 416.33 | 388.71 | 338.37 | 297.89 |
Total Common Equity | 1,032 | 918.34 | 879.93 | 826.74 | 785.14 |
Minority Interest | - | -0.02 | 0.17 | - | - |
Shareholders' Equity | 1,032 | 918.32 | 880.1 | 826.74 | 785.14 |
Total Liabilities & Equity | - | 1,648 | 1,316 | 1,108 | 956.62 |
Total Debt | 568.1 | 482.42 | 261.7 | 102.64 | 32.89 |
Net Cash (Debt) | -273.35 | -243.56 | 7.43 | 269.48 | 378.68 |
Net Cash Growth | - | - | -97.24% | -28.84% | 192.35% |
Net Cash Per Share | -1.73 | -1.53 | 0.05 | 1.73 | 2.68 |
Filing Date Shares Outstanding | 157.39 | 157.39 | 156.8 | 156.8 | 156.8 |
Total Common Shares Outstanding | 157.39 | 157.39 | 156.8 | 156.8 | 156.8 |
Working Capital | - | 174.75 | 368.03 | 440.89 | 489.55 |
Book Value Per Share | 6.56 | 5.83 | 5.61 | 5.27 | 5.01 |
Tangible Book Value | 951.22 | 878.15 | 844.45 | 790.44 | 748.66 |
Tangible Book Value Per Share | 6.04 | 5.58 | 5.39 | 5.04 | 4.77 |
Buildings | - | 235.44 | 104.44 | 101.29 | 96.46 |
Machinery | - | 318.26 | 254.46 | 44.74 | 198.53 |
Construction In Progress | - | 348.97 | 274.37 | 83.64 | 50.06 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.